Chemours Company (The) (NYSE: CC) is one of 36 publicly-traded companies in the “Commodity Chemicals” industry, but how does it compare to its peers? We will compare Chemours Company (The) to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Insider and Institutional Ownership

72.9% of Chemours Company (The) shares are held by institutional investors. Comparatively, 69.2% of shares of all “Commodity Chemicals” companies are held by institutional investors. 1.1% of Chemours Company (The) shares are held by company insiders. Comparatively, 8.2% of shares of all “Commodity Chemicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dividends

Chemours Company (The) pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Chemours Company (The) pays out 8.3% of its earnings in the form of a dividend. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 47.6% of their earnings in the form of a dividend.

Volatility & Risk

Chemours Company (The) has a beta of 3.59, suggesting that its share price is 259% more volatile than the S&P 500. Comparatively, Chemours Company (The)’s peers have a beta of 1.11, suggesting that their average share price is 11% more volatile than the S&P 500.

Earnings & Valuation

This table compares Chemours Company (The) and its peers top-line revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Chemours Company (The) $5.40 billion $7.00 million 35.80
Chemours Company (The) Competitors $4.14 billion $352.97 million 114.40

Chemours Company (The) has higher revenue, but lower earnings than its peers. Chemours Company (The) is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Chemours Company (The) and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemours Company (The) 4.86% 116.80% 8.10%
Chemours Company (The) Competitors -25.38% 22.95% 5.95%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Chemours Company (The) and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours Company (The) 0 0 7 0 3.00
Chemours Company (The) Competitors 106 825 1213 34 2.54

Chemours Company (The) presently has a consensus price target of $52.71, suggesting a potential upside of 1.55%. As a group, “Commodity Chemicals” companies have a potential upside of 2.46%. Given Chemours Company (The)’s peers higher possible upside, analysts clearly believe Chemours Company (The) has less favorable growth aspects than its peers.

Summary

Chemours Company (The) beats its peers on 9 of the 15 factors compared.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.